Paul Verweij

80PUBLICATIONS
258CO-AUTHORS
Medical infection agents (incl. prions)Environmental epidemiologyInfectious agentsGenetically modified treesMedical microbiology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (80)

|Aug 05, 2026
Establishment of epidemiological cutoff values for yeast-phase Talaromyces marneffei against six antifungal agents: a multicenter study in China.

|Jul 03, 2026
Risk factors for acquisition and severity of Acanthamoeba and Fusarium keratitis in contact lens users-A case-control and clinical-epidemiological study, 2009-2020.

|Jun 02, 2026
The black aspergilli (Aspergillus niger complex) and their role in human, animal, and plant diseases.

|Apr 27, 2026
Genotype-Phenotype Relationships in Azole-Resistant Aspergillus: Two Sides of the Same Coin.

|Apr 18, 2026
The dual role of azoles: lifesaving antifungals and drivers of resistance - a One Health perspective.

|Feb 03, 2026
Characteristics of individual cyp51A SNPs and combinations thereof impacting the azole phenotype in TR34-mediated resistance genotypes of Aspergillus fumigatus.

Yinggai Song, Jochem B Buil, Jan Zoll

Pageof 14

Frequent Collaborators

22 joint publications

Jochem B Buil

12 joint publications

Willem J G Melchers

12 joint publications

Roger J M Brüggemann

10 joint publications

Joost Wauters